T1	intervention 49 68	electro-acupuncture
T2	condition 91 127	taxane-induced peripheral neuropathy
T4	eligibility 393 465	Women with stage I-III breast cancer scheduled to receive taxane therapy
T5	control 495 527	standardized protocol of 12 true
T9	total-participants 814 817	180
T10	total-participants 842 844	63
T11	total-participants 858 860	48
T12	age 892 907	Mean age was 50
T13	ethinicity 918 923	white
T14	ethinicity 930 935	black
T15	ethinicity 946 954	Hispanic
T17	outcome 988 998	At week 12
T18	outcome 1150 1157	week 16
T22	iv-cont-mean 1121 1124	2.8
T23	cv-cont-mean 1132 1135	2.6
T24	iv-cont-mean 1239 1242	1.7
T25	cv-cont-mean 1250 1253	3.4
T3	outcome 1036 1064	mean BPI-SF worst pain score
T16	outcome 1281 1304	BPI-SF worst pain score
T19	outcome 1501 1519	pain or neuropathy
